Probing the active sites of monoamine oxidase A and B with 1,4- disubstituted tetrahydropyridine substrates and inactivators

Journal of Medicinal Chemistry

Volumn 40, Issue 13, 1997, Pages 1982-1989

  Palmer, Sonya L ^a   Mabic, Stéphane ^a   Castagnoli Jr , Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 (2 PHENYLPHENYL)PYRIDINE OXALATE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 (3 PHENYLPHENYL)PYRIDINE OXALATE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; ENZYMOLOGY; GAS CHROMATOGRAPHY; OXIDATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CATTLE; HUMANS; KINETICS; LIVER; MODELS, CHEMICAL; MODELS, MOLECULAR; MONOAMINE OXIDASE; PLACENTA; PYRIDINES;

EID: 0030968180     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970079r     Document Type: Article

References (41)

1. Strolin Benedetti, M.; Dostert, P.; Tipton, K. F. Contributions of monoamine oxidase to the metabolism of xenobiotics. Prog. Drug Metab. 1988, 11, 149-154.
2. Dostert, P.; Strolin Benedetti, M.; Tipton, K. F. Interactions of monoamine oxidase with substrates and inhibitors. Med. Res. Rev. 1989, 9, 45-89.
3. Kearney, E. B.; Salach, J. J.; Walker, W. H.; Seng, R.; Singer, T. P. Structure of the covalently bound flavin of monoamine oxidase. Biochem. Res. Commun. 1971, 42, 490-491.
4. Back, A. J. W.; Lan, N. C.; Johnson, D. L.; Abell, C. W.; Bembenek, M. E.; Kwan, S. W.; Seeburg, P.; Shih, J. C. cDNA Cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4934-4938.
5. Hsu, Y.-P. P.; Weyler, W.; Chen, S.; Sims, K. B.; Rinehart, W. B.; Utterback, M.; Powell, J. F.; Breakfield, X. O. Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. J. Neurochem. 1988, 51, 1321-1324.
6. Waldmeier, P. C. Amine oxidases and their endogenous substrates (with special references to monoamine oxidase and the brain). J. Neural Transm. Suppl. 1987, 23, 55-72.
7. Cesura, A. M.; Pletscher, A. The new generation of monoamine oxidase inhibitors. Prog. Drug Res. 1992, 38, 174-297.
8. Strolin Benedetti, M.; Dostert, P. Monoamine oxidase: From physiology and pathophysiology to the design and clinical application of reversible inhibitors. Adv. Drug Res. 1992, 23, 65-125.
9. Kalgutkar, A. S.; Castagnoli, N., Jr.; Testa, B. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism. Med. Res. Rev. 1995, 15, 325-389.
10. Wang, Y.-X.; Castagnoli, N., Jr. Studies on the monoamine oxidase (MAO)-catalyzed oxidation of phenyl-substituted 1-methyl-4-phenoxy-1,2,3,6-tetrahydropyridine derivatives: Factors contributing to MAO-A and MAO-B selectivity. J. Med. Chem. 1995, 38, 1904-1910.
11. Nimkar, S. K.; Anderson, A.; Rimoldi, J. M.; Stanton, M.; Castagnoli, K. P.; Mabic, S.; Wang, X.-Y.; Castagnoli, N., Jr. Synthesis and MAO-B catalyzed oxidation of C-4 heteroaromatic substituted MPTP analogs. Chem. Res. Toxicol. 1996, 9, 1013-1022.
12. Rimoldi, J. M.; Wang, Y.-X.; Nimkar, S. K.; Kuttab, S. H.; Anderson, A. H.; Burch, H.; Castagnoli, N., Jr. Probing the mechanism of bioactivation of MPTP type analogs by monoamine oxidase B: Structure-activity studies on substituted 4-phenoxy-, 4-phenyl, and 4-thiophenoxy-1-cyclopropyl-1,2,3,6-tetrahydropyridines. Chem. Res. Toxicol. 1995, 8, 703-710.
13. Langston, W. J. Mechanisms underlaying neuronal degeneration in Parkinson's disease: An experimental and theoretical treatise. Movement Disorders 1989, 4, S15-S25.
14. Singer, T. P.; Ramsay, R. R.; Sonsalla, P. K.; Nicklas, W. J.; Heikkila, R. E. Biochemical mechanism underlying MPTP-induced and idiopathic parkinsonism. Advances in neurology, Parkinson's disease from basic research to treatment; Raven Press: New York, 1993; pp 300-305.
15. Youngster, S. K.; Sonsalla, P. K.; Heikkila, R. E. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem. 1987, 929-934.
16. Altomare, C.; Carrupt, P. A.; Gaillard, P.; El Tayar, N.; Testa, B.; Carotti, A. Quantitative structure-metabolism relationship analyses of MAO-mediated toxication of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and analogues. Chem. Res. Toxicol. 1992, 5, 366-375.
17. Langston, J. W.; Irwin, I.; Langston, E. B.; Forno, L. S. The importance of 4′-5′ double bond for neurotoxicity in primates of the pyridine derivative MPTP. Neurosci. Lett. 1984, 50, 289-294.
18. Brossi, A. Further exploration of unnatural alkaloids. J. Nat. Prod. 1985, 48, 878-893.
19. Fries, D. S.; Vries, J.; Hazelhoff, B.; Horn, A. S. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues. J. Med. Chem. 1986, 29, 424-427.
20. Maret, G.; Testa, B.; Jenner, P.; El Tayar, N.; Carrupt, P. A. The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. Drug Metab. Rev. 1990, 22, 291-332.
21. Maret, G.; Tayar, N.; Carrupt, P.-A.; Testa, B.; Jenner, P.; Bairds, M. Toxication of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and analogs by monoamine oxidase. Biochem. Pharmacol. 1990, 40, 783-792.
22. Youngster, S. K.; McKeon, K. A.; Jin, Y.-Z.; Ramsay, R. R.; Heikkila, R. E.; Singer, T. P. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products. J. Neurochem. 1989, 53, 1837-1842.
23. Tipton, K. F.; Singer, T. P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 1993, 61, 1191-1206.
24. Efange, S. M. N.; Boudreau, R. J. Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J. Comput.-Aided Mol. Des. 1991, 5, 405-417.
25. Efange, S. M. N.; Michelson, R. H.; Tan, A. K.; Krueger, M. J.; Singer, T. P. Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B. J. Med. Chem. 1993, 36, 1278-1283.
26. Kalgutkar, A. S.; Castagnoli, K.; Hall, A.; Castagnoli, N., Jr. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates. J. Med. Chem. 1994, 37, 944-949.
27. Agarwal, A.; Pearson, P. P.; Taylor, E. W.; Li, H. B.; Dahlgren, T.; Herslof, M.; Yang, Y.; Lambert, G.; Nelson, D. L.; Regan, J. W.; Martin, A. R. Three dimensional quantitative structure-activity relationship of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: A comparison of the Hansch and CoMFA methods. J. Med. Chem. 1993, 36, 4006-4014.
28. Mabic, S.; Castagnoli, N., Jr. Assessment of structural requirements for the MAO-B catalyzed oxidation of 1,4-disubstituted tetrahydropyridine derivatives related to the neurotoxin MPTP. J. Med. Chem. 1996, 39, 3694-3700.
29. Ramsay, R. R.; Singer, T. P. The kinetic mechanisms of monoamine oxidases A and B. Biochem. Soc. Trans. 1991, 19, 219-223.
30. Youngster, S. K.; Sonsalla, P. K.; Sieber, B.-A.; Heikkila, R. E. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. J. Pharmacol. Exp. Ther. 1989, 249, 820-828.
31. Singer, T. P.; Ramsay, R. R. The interaction of monoamine oxidases with tertiary amines. Biochem. Soc. Trans. 1991, 19, 211-214.
32. Silverman, R. B.; Hoffman, S. J. Mechanism of inactivation of mitochondrial monoamine oxidase by N-cyclopropyl,N-arylalkylamines. J. Am. Chem. Soc. 1980, 102, 884-886.
33. Hall, L.; Murray, S.; Castagnoli, K.; Castagnoli, N., Jr. Studies on 1,2,3,6-tetrahydropyridine derivatives as potential monoamine oxidase inactivator. Chem. Res. Toxicol. 1992, 5, 625-633.
34. Stewart, J. J. P. Semiempirical molecular orbital methods. In Reviews in computational chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH: Weinheim, 1990; Vol. 1, pp 45-81.
35. Dewar, M. J. S.; Zoebish, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 8646-8643.
36. A thorough discussion of the assumptions and limitations of this method will be proposed in a paper currently in preparation.
37. The fate and binding properties of 37 in MAO-A and MAO-B active sites are discussed in details in reference 36. Briefly, the flexibility around the oxygen is the reason for the low SCA/B observed.
38. Pitts, S. M.; Markey, S. P.; Murphy, D. L.; Weisz, A. Recommended practices for the safe handling of MPTP. MPTP-A Neurotoxin Producing a Parkinsonian Syndrome; Academic Press: New York, 1995.
39. Kuttab, S.; Kalgutkar, A.; Castagnoli, N., Jr. Mechanistic studies on the monoamine oxidase B catalyzed oxidation of 1,4-disubstituted tetrahydropyridines. Chem. Res. Toxicol. 1994, 7, 740-744.
40. Salach, J. I.; Weyler, W. Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver. In Methods in Enzymology; Kaufman, S., Ed.; Academic Press: London, 1987; Vol. 142, pp 627-637.
41. Zhao, Z.; Dalvie, D.; Naiman, N.; Castagnoli, K.; Castagnoli, N., Jr. Design, synthesis, and biological evaluation of novel 4-substituted-1-methyl-1,2,3,6-tetrahydropyridine analogs of MPTP. J. Med. Chem. 1992, 35, 4473-4478.